Bayer Faces Massive Settlement Over Roundup Lawsuits

Clear Facts

• Bayer’s Monsanto unit agreed to up to $7.25 billion settlement to resolve current and future lawsuits alleging Roundup caused cancer.
• The deal, filed in Missouri state court, sets a 21-year claims program with capped annual payouts.
• About 65,000 U.S. plaintiffs have filed claims, and payouts could reach $198,000 per individual, but Bayer admits no fault.

Bayer reached a proposed settlement for tens of thousands of lawsuits over Roundup, aiming to resolve claims that its weedkiller caused cancer.

The program is designed to handle both current and future claims over the next 21 years, but it depends on a judge’s approval and a minimum number of participants.

Bayer acquired Monsanto and Roundup in 2018, and faces cases from some 65,000 people in state and federal courts across the country.

Payouts will be calculated through a tiered system factoring in exposure level, diagnosis age, and cancer type, with attorney Eric Holland noting individuals may receive up to $198,000 or more.

Bayer said, “Decades of studies have shown Roundup and its active ingredient, glyphosate, are safe for human use.”

The settlement does not require Bayer to admit liability and allows the company to withdraw if too many people reject the offer.

Bayer CEO Bill Anderson expressed confidence the settlement will resolve the majority of claims, though he declined to state the current level of support for the deal.

Attorney Eric Holland, representing plaintiffs, said, “The deal represents the best path forward.”

Bayer expects litigation liabilities to increase and anticipates negative free cash flow this year due to legal costs.

The agreement was reached with several law firms but also includes confidential settlements with others.

The settlement follows the Supreme Court’s decision to hear a significant case that could sharply reduce Bayer’s liability, as Bayer argues that federal law prevents additional cancer warnings.

A win at the Supreme Court could eliminate several large verdicts and reduce future claims, but some investors remain cautious.

Markus Manns, a Bayer investor, warned, “The settlement buys Bayer time, but without a win in the Supreme Court, a new wave of lawsuits could roll over Bayer in a few years.”

Roundup remains widely available in stores despite these ongoing legal challenges, with some consumers questioning its safety and effectiveness.

One individual reflected, “Glyphosate will be looked back on in the future as a crime against humanity.”

Let us know what you think, please share your thoughts in the comments below.

Read more at The Daily Wire